Reduced bone density in HIV-infected women - PubMed (original) (raw)
Reduced bone density in HIV-infected women
Sara E Dolan et al. AIDS. 2004.
Abstract
Objectives: Although bone density has been previously investigated in HIV-infected men, little is known regarding bone density in HIV-infected women.
Methods and design: Bone density was measured by dual-energy X-ray absorptiometry in 84 ambulatory, HIV-infected females and 63 healthy female control subjects similar in age (41 +/-1 versus 41+/- 1 years, P = 0.83), body mass index (26.0 +/- 0.6 versus 27.0 +/- 0.5 kg/m, P = 0.44) and racial background (% non-Caucasian, 61 versus 51%; P = 0.24, HIV-infected versus control).
Results: Lumbar spine (1.02+/- 0.02 versus 1.07 +/- 0.02 g/cm, P = 0.03) and total hip (0.93 +/-0.01 versus 0.99 +/- 0.01 g/cm, P = 0.004) bone density were reduced in HIV-infected compared with control subjects. Osteopenia was demonstrated in 54 versus 30% (P = 0.004) of HIV-infected versus control subjects and was 2.5 times more likely in a multivariate model accounting for age, race, menstrual function and body mass index. Urinary N-telopeptides of type 1 collagen (NTx) (39.6 +/- 3.5 versus 29.9 +/- 2.0 nM/mM urine creatinine, P = 0.03) and osteoprotegerin (4.76 +/- 0.23 versus 3.39 +/- 0.17 pmol/l, P < or = 0.0001) were increased in HIV-infected compared with control subjects. Among the HIV-infected women, bone density correlated with weight (r = 0.41, P < 0.001) and inversely with urinary NTx (r = -0.28, P = 0.01). Bone density did not differ by current or past protease inhibitor, nucleoside reverse trancriptase inhibitor, or non-nucleoside reverse transcriptase inhibitor exposure.
Conclusions: HIV-infected women demonstrate reduced bone density. Altered nutritional status, hormonal function and body composition may contribute to lower bone density in HIV-infected women. Consideration should be given to testing bone density in HIV-infected women with risk factors for osteopenia.
Similar articles
- Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
Dolan SE, Kanter JR, Grinspoon S. Dolan SE, et al. J Clin Endocrinol Metab. 2006 Aug;91(8):2938-45. doi: 10.1210/jc.2006-0127. Epub 2006 May 30. J Clin Endocrinol Metab. 2006. PMID: 16735489 Free PMC article. - Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S. Huang JS, et al. AIDS. 2001 May 25;15(8):975-82. doi: 10.1097/00002030-200105250-00005. AIDS. 2001. PMID: 11399979 - Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women.
Dolan SE, Carpenter S, Grinspoon S. Dolan SE, et al. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):161-7. doi: 10.1097/QAI.0b013e31804a7f4d. J Acquir Immune Defic Syndr. 2007. PMID: 17527091 - Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR, Moreno S, Cacopardo B, Nunnari G. Pinzone MR, et al. AIDS Rev. 2014 Oct-Dec;16(4):213-22. AIDS Rev. 2014. PMID: 25300622 Review. - Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.
Bongiovanni M, Tincati C. Bongiovanni M, et al. Curr Mol Med. 2006 Jun;6(4):395-400. doi: 10.2174/156652406777435435. Curr Mol Med. 2006. PMID: 16900662 Review.
Cited by
- Comparison of healthspan-related indicators between adults with and without HIV infection aged 18-59 in the United States: a secondary analysis of NAHNES 1999-March 2020.
Chen C, Cao X, Xu J, Jiang Z, Liu Z, McGoogan J, Wu Z. Chen C, et al. BMC Public Health. 2023 May 4;23(1):814. doi: 10.1186/s12889-023-15538-6. BMC Public Health. 2023. PMID: 37142969 Free PMC article. - IL-27 Modulates the Cytokine Secretion in the T Cell-Osteoclast Crosstalk During HIV Infection.
Li T, Hadigan C, Whitlock JM, Qin J, Kumar J, Kumar P, Catalfamo M. Li T, et al. Front Immunol. 2022 Apr 5;13:818677. doi: 10.3389/fimmu.2022.818677. eCollection 2022. Front Immunol. 2022. PMID: 35479090 Free PMC article. - People living with HIV have low trabecular bone mineral density, high bone marrow adiposity, and poor trabecular bone microarchitecture at the proximal femur.
Carballido-Gamio J, Posadzy M, Wu PH, Kenny K, Saeed I, Link TM, Tien PC, Krug R, Kazakia GJ. Carballido-Gamio J, et al. Osteoporos Int. 2022 Aug;33(8):1739-1753. doi: 10.1007/s00198-022-06405-y. Epub 2022 Apr 27. Osteoporos Int. 2022. PMID: 35478045 Free PMC article. - Human Immunodeficiency Virus (HIV) and Menopause Are Independently Associated With Lower Bone Mineral Density: Results From the Women's Interagency HIV Study.
Sharma A, Hoover DR, Shi Q, Tien PC, Weber KM, Shah JG, Yin MT. Sharma A, et al. Clin Infect Dis. 2022 Aug 24;75(1):65-72. doi: 10.1093/cid/ciab874. Clin Infect Dis. 2022. PMID: 34595517 Free PMC article. - Factors Associated with Bone Mineral Density and Bone Resorption Markers in Postmenopausal HIV-Infected Women on Antiretroviral Therapy: A Prospective Cohort Study.
Ellis C, Kruger HS, Viljoen M, Dave JA, Kruger MC. Ellis C, et al. Nutrients. 2021 Jun 18;13(6):2090. doi: 10.3390/nu13062090. Nutrients. 2021. PMID: 34207469 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 3-M01-RR 01066-25S1/RR/NCRR NIH HHS/United States
- AI51947/AI/NIAID NIH HHS/United States
- DK 59535/DK/NIDDK NIH HHS/United States
- K23 AI051947/AI/NIAID NIH HHS/United States
- K23 AI051947-03/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous